Cell Line : LOU-NH91
Cellosaurus Index : CVCL_2104
Cellosaurus ID : LOU-NH91
CTRP2 Name
: LOUNH91
GDSC1 Name
, GDSC2 Name
: LOU-NH91
CCLE Name
: LOUNH91_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LOU-NH91 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| LOU-NH91 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| LOU-NH91 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| LOU-NH91 | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | abiraterone | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| LOU-NH91 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LOU-NH91 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| LOU-NH91 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| LOU-NH91 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| LOU-NH91 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| LOU-NH91 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| LOU-NH91 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| LOU-NH91 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| LOU-NH91 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | AT-406 | CTRP2 | 0.0320 | 66.0000 |
|
| LOU-NH91 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AT7867 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| LOU-NH91 | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| LOU-NH91 | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LOU-NH91 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| LOU-NH91 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LOU-NH91 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| LOU-NH91 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LOU-NH91 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LOU-NH91 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| LOU-NH91 | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BI-2536 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| LOU-NH91 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| LOU-NH91 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| LOU-NH91 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| LOU-NH91 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| LOU-NH91 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD-K02251932 | CTRP2 | 0.0320 | 66.0000 |
|
| LOU-NH91 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K04800985 | CTRP2 | 0.0081 | 66.0000 |
|
| LOU-NH91 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K09344309 | CTRP2 | 0.0010 | 17.0000 |
|
| LOU-NH91 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| LOU-NH91 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| LOU-NH91 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| LOU-NH91 | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| LOU-NH91 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| LOU-NH91 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD6430 | CTRP2 | 0.0160 | 33.0000 |
|
| LOU-NH91 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| LOU-NH91 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| LOU-NH91 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| LOU-NH91 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| LOU-NH91 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| LOU-NH91 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| LOU-NH91 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| LOU-NH91 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| LOU-NH91 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| LOU-NH91 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| LOU-NH91 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| LOU-NH91 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| LOU-NH91 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| LOU-NH91 | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| LOU-NH91 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| LOU-NH91 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| LOU-NH91 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| LOU-NH91 | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LOU-NH91 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | compound 1B | CTRP2 | 0.0081 | 66.0000 |
|
| LOU-NH91 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| LOU-NH91 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Crizotinib | GDSC2,CTRP2,CCLE | 0.0010 | 66.0000 |
|
| LOU-NH91 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | cucurbitacin I | CTRP2 | 0.0010 | 17.0000 |
|
| LOU-NH91 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LOU-NH91 | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| LOU-NH91 | Dactolisib | GDSC1,GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| LOU-NH91 | Daporinad | GDSC1 | 0.0039 | 1.0000 |
|
| LOU-NH91 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Dasatinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LOU-NH91 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| LOU-NH91 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| LOU-NH91 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| LOU-NH91 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| LOU-NH91 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| LOU-NH91 | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| LOU-NH91 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| LOU-NH91 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| LOU-NH91 | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| LOU-NH91 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| LOU-NH91 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Erlotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| LOU-NH91 | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| LOU-NH91 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| LOU-NH91 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| LOU-NH91 | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| LOU-NH91 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| LOU-NH91 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| LOU-NH91 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LOU-NH91 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| LOU-NH91 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| LOU-NH91 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| LOU-NH91 | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| LOU-NH91 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | gossypol | CTRP2 | 0.0011 | 18.0000 |
|
| LOU-NH91 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| LOU-NH91 | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | GSK1059615 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| LOU-NH91 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LOU-NH91 | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| LOU-NH91 | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| LOU-NH91 | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| LOU-NH91 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| LOU-NH91 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| LOU-NH91 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| LOU-NH91 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| LOU-NH91 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Irinotecan | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| LOU-NH91 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | isonicotinohydroxamic acid | CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| LOU-NH91 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | JW-55 | CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | KHS101 | CTRP2 | 0.0041 | 66.0000 |
|
| LOU-NH91 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| LOU-NH91 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| LOU-NH91 | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | Lapatinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| LOU-NH91 | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | LE-135 | CTRP2 | 0.0020 | 4.2000 |
|
| LOU-NH91 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| LOU-NH91 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| LOU-NH91 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| LOU-NH91 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| LOU-NH91 | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| LOU-NH91 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| LOU-NH91 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| LOU-NH91 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| LOU-NH91 | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| LOU-NH91 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| LOU-NH91 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| LOU-NH91 | ML030 | CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ML258 | CTRP2 | 0.0041 | 66.0000 |
|
| LOU-NH91 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| LOU-NH91 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| LOU-NH91 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LOU-NH91 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | myricetin | CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| LOU-NH91 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 200.0000 |
|
| LOU-NH91 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LOU-NH91 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| LOU-NH91 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Nelarabine | GDSC2,CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Nilotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| LOU-NH91 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| LOU-NH91 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | NSC23766 | CTRP2 | 0.0320 | 530.0000 |
|
| LOU-NH91 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| LOU-NH91 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | NSC632839 | CTRP2 | 0.0160 | 33.0000 |
|
| LOU-NH91 | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LOU-NH91 | Nutlin-3a | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 150.0000 |
|
| LOU-NH91 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| LOU-NH91 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| LOU-NH91 | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | OSI-930 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Paclitaxel | GDSC2,CTRP2,CCLE | 0.0000 | 66.0000 |
|
| LOU-NH91 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| LOU-NH91 | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| LOU-NH91 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| LOU-NH91 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LOU-NH91 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PDMP | CTRP2 | 0.0065 | 110.0000 |
|
| LOU-NH91 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| LOU-NH91 | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| LOU-NH91 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PF-750 | CTRP2 | 0.0081 | 130.0000 |
|
| LOU-NH91 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| LOU-NH91 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| LOU-NH91 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| LOU-NH91 | PI-103 | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| LOU-NH91 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Piperlongumine | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PL-DI | CTRP2 | 0.0081 | 66.0000 |
|
| LOU-NH91 | Platin | CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| LOU-NH91 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| LOU-NH91 | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| LOU-NH91 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| LOU-NH91 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| LOU-NH91 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | Rapamycin | GDSC2,CTRP2 | 0.0000 | 33.0000 |
|
| LOU-NH91 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Remodelin | GDSC2 | 0.0500 | 50.0000 |
|
| LOU-NH91 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| LOU-NH91 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| LOU-NH91 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| LOU-NH91 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| LOU-NH91 | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| LOU-NH91 | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| LOU-NH91 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | SCH-529074 | CTRP2 | 0.0010 | 17.0000 |
|
| LOU-NH91 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| LOU-NH91 | Selumetinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 270.0000 |
|
| LOU-NH91 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LOU-NH91 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LOU-NH91 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LOU-NH91 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LOU-NH91 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| LOU-NH91 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LOU-NH91 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LOU-NH91 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| LOU-NH91 | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LOU-NH91 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | SID 26681509 | CTRP2 | 0.0180 | 300.0000 |
|
| LOU-NH91 | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| LOU-NH91 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| LOU-NH91 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.3000 |
|
| LOU-NH91 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | Sorafenib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | sotrastaurin | CTRP2 | 0.0320 | 66.0000 |
|
| LOU-NH91 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| LOU-NH91 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| LOU-NH91 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| LOU-NH91 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| LOU-NH91 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Tanespimycin | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| LOU-NH91 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LOU-NH91 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| LOU-NH91 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| LOU-NH91 | Teniposide | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| LOU-NH91 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| LOU-NH91 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| LOU-NH91 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | tipifarnib-P2 | CTRP2 | 0.0160 | 33.0000 |
|
| LOU-NH91 | Tivozanib | GDSC1,CTRP2 | 0.0005 | 33.0000 |
|
| LOU-NH91 | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| LOU-NH91 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | Topotecan | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LOU-NH91 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| LOU-NH91 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | Tretinoin | GDSC1,CTRP2 | 0.0041 | 130.0000 |
|
| LOU-NH91 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| LOU-NH91 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| LOU-NH91 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| LOU-NH91 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| LOU-NH91 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Tubastatin A | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | TW 37 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| LOU-NH91 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | UNC0638 | GDSC1,GDSC2,CTRP2 | 0.0010 | 40.0000 |
|
| LOU-NH91 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| LOU-NH91 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| LOU-NH91 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | VAF-347 | CTRP2 | 0.0020 | 33.0000 |
|
| LOU-NH91 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| LOU-NH91 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| LOU-NH91 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LOU-NH91 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| LOU-NH91 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| LOU-NH91 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LOU-NH91 | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| LOU-NH91 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LOU-NH91 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| LOU-NH91 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| LOU-NH91 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| LOU-NH91 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LOU-NH91 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| LOU-NH91 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| LOU-NH91 | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LOU-NH91 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| LOU-NH91 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| LOU-NH91 | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| LOU-NH91 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| LOU-NH91 | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| LOU-NH91 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| LOU-NH91 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LOU-NH91 | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| LOU-NH91 | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC